Overview

This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one. This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.

Full Product Details

9780471627449

Table of Contents

Reviews

It does successfully convey to the reader areas of controversy (Microbiology Today, November 2001)<br><br> there are a number of nuggets in the book that make it worth a browse. (Pharmaceutical Physician, December 2001)<br><br> I found this book fun to read. (Biochemistry & Molecular Biology Education, No.29 2001)<br><br> Contributors...present 17 papers and the discussions they generated at the symposium. (SciTech Book News, Vol. 25, No. 4, December 2001)

It does successfully convey to the reader areas of controversy (Microbiology Today, November 2001) <br> there are a number of nuggets in the book that make it worth a browse. (Pharmaceutical Physician, December 2001) <br> I found this book fun to read. (Biochemistry & Molecular Biology Education, No.29 2001) <br> Contributors...present 17 papers and the discussions they generated at the symposium. (SciTech Book News, Vol. 25, No. 4, December 2001)

It does successfully convey to the reader areas of controversy (Microbiology Today, November 2001) there are a number of nuggets in the book that make it worth a browse. (Pharmaceutical Physician, December 2001) I found this book fun to read. (Biochemistry & Molecular Biology Education, No.29 2001) Contributors...present 17 papers and the discussions they generated at the symposium. (SciTech Book News, Vol. 25, No. 4, December 2001)

It does successfully convey to the reader areas of controversy (Microbiology Today, November 2001) there are a number of nuggets in the book that make it worth a browse. (Pharmaceutical Physician, December 2001) I found this book fun to read. (Biochemistry & Molecular Biology Education, No.29 2001) Contributors...present 17 papers and the discussions they generated at the symposium. (SciTech Book News, Vol. 25, No. 4, December 2001)

It does successfully convey to the reader areas of controversy (Microbiology Today, November 2001) there are a number of nuggets in the book that make it worth a browse. (Pharmaceutical Physician, December 2001) I found this book fun to read. (Biochemistry & Molecular Biology Education, No.29 2001) Contributors...present 17 papers and the discussions they generated at the symposium. (SciTech Book News, Vol. 25, No. 4, December 2001)

Author Information

The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available